Years of being dismissed can make a person willing to try almost anything.
In the quiet accumulation of years without a diagnosis, a young woman's suffering found its way into the hands of those unqualified to hold it. On Tuesday in Montreal, naturopath Kadeja Lefebvre pleaded guilty to practising medicine without authorization and was fined $15,000 — a legal resolution that closes one chapter in the story of Amélie Champagne, who died by suicide at 22 after years of medical uncertainty and treatment that may have led her to believe she had a disease never formally confirmed. The case asks an enduring question about the systems meant to protect the vulnerable: what becomes of those who fall through every gap, and who is accountable when belief itself becomes a form of harm.
- A 22-year-old who had spent six years cycling through undiagnosed symptoms turned to a naturopath operating outside the bounds of licensed medicine — and died by suicide weeks after her condition visibly deteriorated.
- Kadeja Lefebvre began treating Amélie Champagne for Lyme disease before any formal diagnosis existed and before Champagne had even met the referring physician, exposing her to costly treatment with adverse effects.
- A coroner's inquiry found that Champagne may have been misled into believing she had Lyme disease, with laboratory results later used to support her diagnosis explicitly flagged as suitable only for research purposes.
- Lefebvre pleaded guilty to three charges and paid $15,000 in fines — a negotiated settlement that avoided trial but left deeper institutional questions unanswered.
- A coroner issued 19 recommendations, including calls for the Collège des médecins to scrutinize both Lefebvre's naturopathic practice and the conduct of the private-clinic physicians who treated Champagne in her final months.
- Whether Quebec's medical establishment acts on those findings will determine whether the next patient carrying years of unanswered symptoms finds protection — or the same dangerous void.
Amélie Champagne was 22 years old, a university student who appeared, from the outside, to be living a full life. But she had been suffering since she was 16 — fatigue, insomnia, lost appetite, symptoms that cycled without resolution. Specialists considered multiple sclerosis, vestibular syndrome, fibromyalgia. None of the diagnoses held. She moved through Quebec's public system feeling profoundly misunderstood. On September 11, 2022, she died by suicide in Montreal.
On Tuesday, naturopath Kadeja Lefebvre stood before Quebec Court Judge Alexandre St-Onge and pleaded guilty to three charges brought by the Collège des médecins du Québec: practising medicine without authorization in 2022, prescribing substances to Champagne, and treating a second patient without authorization. Eight additional charges were dropped as part of a negotiated settlement. The fine totalled $15,000.
The fuller story emerged during a 2024 coroner's inquiry. Coroner Julie Kim-Godin traced how Champagne, beginning in 2020, had consulted psychiatrists, neurologists, and general practitioners without ever receiving a firm diagnosis. She eventually came under the care of a Lyme-specialist physician who worked alongside Lefebvre — and Lefebvre began naturopathic treatment for Lyme disease before any diagnosis had been confirmed and before Champagne had met the referring doctor in person. The treatment was expensive and produced adverse effects.
A diagnosis of Lyme disease eventually came through a video consultation, and Champagne was directed toward American specialists. Laboratory results from the United States returned positive for a co-infection — but the lab's own documentation stated those results were to be interpreted with caution and used only for research. The coroner asked plainly whether Champagne had been led to believe she had a disease that was never truly established.
In the weeks before her death, those close to her watched her withdraw, lose weight, and struggle with exhaustion and sleeplessness. The coroner's report was not designed to assign legal blame but to prevent future harm. Among its 19 recommendations, two called on the Collège des médecins to examine both Lefebvre's practice and the conduct of the private-clinic physicians who treated Champagne — their communication with her, the quality of their assessments, and how they monitored her wellbeing.
The fine closes the legal file on Lefebvre. What remains open is whether the institutions responsible for medical oversight will act on what the coroner found — and whether that action will come in time to matter for the next patient who arrives somewhere desperate, undiagnosed, and in need of being believed.
Amélie Champagne was 22 years old, a university student who held a part-time job, traveled with her family, and kept up with sports and hobbies. To anyone looking in from the outside, her life appeared full and well-ordered. But she had been quietly suffering since she was 16 — cycling through fatigue, insomnia, lost appetite, and a constellation of symptoms that no doctor had ever been able to name with certainty. Multiple sclerosis was considered. So were vestibular syndrome and fibromyalgia. None of them stuck. She moved from specialist to specialist inside Quebec's public system, feeling, as those close to her would later describe it, profoundly misunderstood and alone. On September 11, 2022, she died by suicide in Montreal.
On Tuesday, a naturopath who treated Champagne in the months before her death stood briefly before Quebec Court Judge Alexandre St-Onge at the Montreal courthouse and pleaded guilty to three charges. Kadeja Lefebvre, accused by the Collège des médecins du Québec of practising medicine without authorization, agreed to pay $15,000 in fines — $5,000 for each count. Eight additional charges against her were dropped as part of a negotiated settlement. The judge observed that the guilty pleas spared everyone a trial that would have run a full week.
The charges to which Lefebvre admitted were specific: she had practised medicine during 2022 while holding no membership in the Collège des médecins, and she had prescribed medicines and other substances to Champagne — both clear violations of the professional order's rules. A third charge involved a separate patient she had also treated without authorization.
The fuller picture of what led Champagne to Lefebvre's door emerged during a coroner's inquiry held in 2024. Coroner Julie Kim-Godin's report traced the arc of a young woman who had spent years convinced that her symptoms pointed to Lyme disease — a tick-borne infection that, when caught late, can produce serious complications — while the medical system around her remained inconclusive. Beginning in 2020, during the pandemic, Champagne consulted a psychiatrist, a neurologist, and other physicians. Most addressed her symptoms without landing on a diagnosis.
Eventually, Champagne began seeing a general practitioner who specialized in Lyme disease and worked alongside Lefebvre. According to the coroner's account, Lefebvre moved forward with a naturopathic treatment for Lyme disease before any formal diagnosis had been confirmed — and before Champagne had even met the referring doctor in person. The treatment came at considerable cost to Champagne. It also produced adverse effects. The coroner's report asked plainly whether Champagne had been led, through the words and actions of those treating her, to believe she had a disease that had not yet been established.
The general practitioner later diagnosed Champagne with Lyme disease through a video consultation and directed her toward specialists in the United States rather than Quebec, citing the quality of American testing. A subsequent specialist informed Champagne in late June 2022 that American laboratory results had come back positive for Babesia odocoilei, described as a co-infection of Lyme disease. The coroner noted that the laboratory's own documentation stated those results should be interpreted with caution and used only for research purposes.
In the weeks before her death, Champagne's decline was visible to those around her. She had withdrawn from her routines, lost weight, and was struggling with sleeplessness and exhaustion. The coroner's report did not set out to assign legal responsibility for her death. Its purpose was prevention — to understand the conditions that led to this outcome and to recommend changes that might protect others.
Among the 19 recommendations Kim-Godin issued, two were directed squarely at the Collège des médecins. The first called on the professional order to examine the quality of Lefebvre's naturopathic practice and the care she provided in 2022. The second asked the Collège to scrutinize the professional and ethical conduct of the private-clinic physicians who treated Champagne that same year — specifically their communication with her, the quality of their assessments, and how they monitored her physical and psychological health.
The $15,000 fine closes the legal chapter for Lefebvre, but the coroner's recommendations leave the institutional questions open. Whether the Collège des médecins acts on those findings — and how — will determine what, if anything, changes for the next patient who arrives at a private clinic carrying years of unanswered symptoms and a desperate need to be believed.
Citas Notables
On the surface, she seemed to lead a perfect life — but from her teenage years onward, she sought to understand the cause of her numerous symptoms and tried to find solutions, enduring years of medical uncertainty without any clear direction. She felt particularly misunderstood and alone.— Coroner Julie Kim-Godin, from her report on Amélie Champagne's death
It is astonishing to learn that such a naturopathic treatment was sold to Champagne for a considerable sum, especially since she had not yet seen the doctor in person and had not been diagnosed with Lyme disease.— Coroner Julie Kim-Godin
La Conversación del Hearth Otra perspectiva de la historia
What strikes you most about this case — the legal outcome or the story behind it?
The legal outcome is almost beside the point. Fifteen thousand dollars is a fine, not a reckoning. The story behind it is about a young woman who spent years being told, in effect, that her suffering didn't have a name.
She saw a lot of doctors. Why did she end up with a naturopath?
Because the system she was moving through kept offering her uncertainty. When you've been bounced between specialists for years without a diagnosis, someone who seems willing to act — to actually treat you — can feel like relief.
Is that what Lefebvre offered? The appearance of certainty?
The coroner's report suggests something like that. Treatment began before a diagnosis was confirmed, before Champagne had even met the referring doctor face to face. Whether that felt like confidence or was simply recklessness, the effect on Champagne may have been the same.
The American lab results were flagged as research-use only. Did anyone tell her that?
That's one of the sharpest questions the coroner raised. The documentation said to interpret those results with caution. Whether that caveat was communicated clearly to a young woman who had been searching for answers for six years — that's a different matter entirely.
The coroner didn't assign blame. Does that frustrate you?
It's the right legal posture for a coroner's inquiry. But it does mean the weight of the findings falls on institutions rather than individuals. The Collège des médecins now has 19 recommendations sitting in front of it. What it does with them is the real test.
What does this case say about the boundary between naturopathy and medicine?
It says the boundary is porous in ways that can be genuinely dangerous, especially when patients are vulnerable and desperate. Lefebvre wasn't operating in a vacuum — she was working alongside a licensed physician. That proximity may have lent her practice a credibility it hadn't earned.
What should readers take away from Amélie Champagne's story?
That years of being dismissed by a system can make a person willing to try almost anything. And that the people who step into that gap carry a serious responsibility — one that, in this case, wasn't honored.